Mineral vs. Chemical Sunscreen: What the FDA's Unfinished Safety Review Actually Means for You

Walk into any American pharmacy and you will find sunscreen shelves divided, at least implicitly, into two camps. On one side sit products proudly labeled "mineral" or "physical," featuring zinc oxide and titanium dioxide as their active ingredients. On the other sit a broader range of formulations relying on compounds like oxybenzone, avobenzone, and octinoxate — the chemical filters that have dominated the US market for decades. Consumers are increasingly told that one category is safe and the other is suspect, but that framing obscures a considerably more complicated scientific picture.

The real story begins not in a dermatology clinic, but in a regulatory document.

What the FDA Actually Said — and When It Said It

In 2019, the US Food and Drug Administration proposed a rule that fundamentally changed how sunscreen ingredients are classified. Under the proposal, only two active ingredients — zinc oxide and titanium dioxide — were deemed "generally recognized as safe and effective" (GRASE). Twelve chemical filters, including widely used compounds such as oxybenzone and avobenzone, were reclassified as lacking sufficient safety data to meet that standard. Two additional ingredients, PABA and trolamine salicylate, were deemed not safe and effective outright.

It is important to understand what that reclassification does and does not mean. The FDA did not declare chemical filters dangerous. It stated that the available data were insufficient to conclude they were safe under the GRASE standard — a regulatory threshold that, for over-the-counter drugs like sunscreen, requires a higher evidentiary bar than many consumers realize. The agency explicitly called for additional research, particularly on systemic absorption.

That research request was not without basis. A 2019 FDA-sponsored clinical study published in JAMA found that four chemical filters — avobenzone, oxybenzone, octocrylene, and ecamsule — were absorbed into the bloodstream at concentrations exceeding the threshold that would typically trigger further safety evaluation. A follow-up study in 2020 confirmed and extended these findings. The key phrase here is "trigger further evaluation." Detection in the bloodstream does not, by itself, establish harm. Caffeine, for example, is measurable in plasma after topical application, and no one considers coffee cups a public health emergency.

Nevertheless, the FDA's concern is scientifically legitimate: when a compound is absorbed systemically and used repeatedly over a lifetime, beginning in childhood, the absence of long-term safety data is a meaningful gap rather than a technicality.

Why the Review Remains Incomplete

As of the time of writing, the FDA has not finalized its sunscreen monograph — the regulatory framework governing which active ingredients are permitted and under what conditions. This process, which should have been completed years ago, has been delayed by a combination of bureaucratic complexity, industry lobbying, and the sheer volume of data required.

The practical consequence is a regulatory limbo that affects consumers in ways most never consider. Dozens of UV filter compounds used routinely in Europe, Australia, and Japan remain unavailable in the United States, not because they have been found unsafe, but because the FDA's approval pathway for new sunscreen ingredients is extraordinarily slow. The Sunscreen Innovation Act of 2014 was specifically designed to accelerate this process, yet most of the ingredients submitted for review under that act have still not received a final determination.

This means American consumers are choosing between a small, aging portfolio of approved ingredients while residents of other developed nations have access to newer filters — including some that offer superior photostability, broader UV coverage, and more favorable absorption profiles. Tinosorb S, Tinosorb M, and Mexoryl SX, for instance, are widely available in Europe and are considered effective, well-tolerated options by international dermatological bodies. None are currently available in US sunscreens.

How Mineral Filters Actually Work — and Their Limitations

Zinc oxide and titanium dioxide function primarily by scattering and reflecting UV radiation, though they also absorb it to a meaningful degree. This distinction from purely chemical mechanisms is often overstated in consumer marketing, but their mode of action does confer certain practical advantages. Both compounds sit on the skin's surface rather than penetrating it, which is why they received GRASE status without controversy. They are also less likely to degrade in sunlight — a significant stability advantage over some chemical alternatives.

Zinc oxide offers particularly broad-spectrum coverage, blocking both UVA and UVB radiation effectively. Titanium dioxide performs well against UVB and short-wave UVA but is less effective at the longer UVA wavelengths. For this reason, zinc oxide is generally the more protective single mineral ingredient, and many dermatologists consider it the gold standard for sensitive skin, infants, and individuals with conditions such as rosacea or post-procedure skin.

The limitations are real, however. Mineral filters have historically left a white cast on darker skin tones — a cosmetic barrier that has contributed to lower sunscreen use in communities that already face elevated risks from certain skin conditions. Newer micronized and nano-formulations reduce this effect, though they introduce their own set of questions about nanoparticle safety that researchers continue to investigate. Additionally, mineral sunscreens tend to feel heavier and may pill under makeup, reducing the likelihood of adequate and consistent application.

Chemical Filters: The Case for Continued Use

For all the regulatory uncertainty surrounding chemical UV filters, the dermatological consensus remains that using them is substantially safer than not using sunscreen at all. Skin cancer is the most common cancer in the United States, with melanoma rates continuing to rise. Unprotected UV exposure is a well-established causal factor. Against that backdrop, the theoretical risks associated with systemic absorption of chemical filters — which remain unquantified in terms of actual clinical harm — must be weighed against the documented, quantifiable harm of UV damage.

Chemical filters also offer formulation advantages that affect real-world protection. They tend to spread more evenly, integrate more seamlessly into daily-use products like moisturizers and foundations, and are more likely to be applied consistently and in sufficient quantity. A mineral sunscreen applied too sparingly because it feels uncomfortable provides less protection than a chemical sunscreen applied correctly.

Avobenzone, despite its instability concerns, remains the only FDA-approved chemical filter that covers the full UVA spectrum. It is typically stabilized through combination with other ingredients like octocrylene — itself under scrutiny for potential conversion to benzophenone over time, though evidence of harm remains limited.

Reef Safety: Science Versus Legislation

Oxybenzone and octinoxate have been banned in Hawaii, the US Virgin Islands, and several other jurisdictions based on concerns about coral reef damage. Laboratory studies have shown that these compounds can affect coral larvae at measurable concentrations. The ecological science, however, is more contested than the legislation suggests. Some marine biologists argue that the concentrations found in reef environments are orders of magnitude lower than those used in laboratory toxicity studies, and that other stressors — particularly ocean warming — represent far greater threats to reef health.

This is not an argument for ignoring environmental impact, but rather a caution against treating reef-safety claims as settled science when the field remains active and somewhat divided.

Making a Practical Decision

The most defensible approach for most Americans is pragmatic rather than ideological. Zinc oxide-based mineral sunscreens are a sound choice for facial use, sensitive skin, and children, particularly given their stability and surface-level activity. For body coverage during extended outdoor activity — where consistent, adequate application is the limiting factor — a well-formulated chemical or combination sunscreen may offer better real-world performance.

The broader takeaway from the FDA's unfinished review is not that chemical sunscreens should be avoided, but that the US regulatory system has fallen significantly behind the science. Until that gap closes, consumers are best served by understanding the available evidence, applying whatever sunscreen they will actually use consistently, and recognizing that imperfect protection applied reliably outperforms ideal protection that stays in the cabinet.